Filters
Results 1 - 1 of 1
Results 1 - 1 of 1.
Search took: 0.014 seconds
AbstractAbstract
[en] Particles or 'seeds' are manufactured for implantation into tumors within a human body for emitting X-rays to destroy or reduce the tumors. The seeds contain palladium which is substantially enriched in palladium-102 and which is activated by exposure to neutron flux so as to contain a minor, but significant, fraction of X-ray-emitting palladium-103. The palladium is distributed on or throughout a base material so as to reduce selfshielding by the palladium. The seeds include an X-ray-opague marker to faciliate external visualization of the seeds after their implantation, the marker preferable being formed of a material, such as lead or rhodium, which does not activate to contain undesirable isotopes under the radiation conditions in which palladium-102 is activated to palladium-103. The base material-distributed palladium and the marker are encased in an elongated shell which is formed by welding a pair of end caps to a tubular member, the construction of the shell reducing the mass of material at the end of the seed, thereby providing a more isotropic angular distribution of X-rays
Primary Subject
Source
7 Aug 1986; 4 Feb 1986; 31 p; ZA PATENT DOCUMENT 86/0810/A/; Available from the Patents Office, Private Bag X400, Pretoria, 0001, South Africa; ?: 4 Feb 1986
Record Type
Patent
Country of publication
BETA DECAY RADIOISOTOPES, DAYS LIVING RADIOISOTOPES, DISEASES, ELECTROMAGNETIC RADIATION, ELECTRON CAPTURE RADIOISOTOPES, ELEMENTS, EVEN-EVEN NUCLEI, EVEN-ODD NUCLEI, INTERMEDIATE MASS NUCLEI, IONIZING RADIATIONS, ISOTOPES, METALS, NUCLEI, PALLADIUM ISOTOPES, PLATINUM METALS, RADIATION FLUX, RADIATIONS, RADIOISOTOPES, STABLE ISOTOPES, TRANSITION ELEMENTS
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue